$5.15 -0.10 (-1.91%) Sorrento Therapeutics Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 5.15
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: -0.10 (-1.91%)
Prev Close: 5.25
Open: 5.25
Bid: 5.15
Ask: 5.20
  1. No results found.
  1. Benzinga's Top Initiations

    Benzinga | Dec. 22, 2015 | 10:01AM EST
  2. Sorrento Therapeutics And City Of Hope Announce Exclusive License To Develop First-In-Class Immunotherapies Against Intracellular Targets

    Benzinga | Sep. 28, 2015 | 05:02AM EST
  3. Sorrento's TNK Therapeutics Subsidiary Acquires Multiple Clinical Stage CAR-T Immunotherapy Programs , no terms

    Benzinga | Aug. 10, 2015 | 05:00AM EST
  4. Sorrento Therapeutics In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies from Mabtech Limited

    Benzinga | Aug. 3, 2015 | 05:04AM EST
  5. Benzinga's Weekend M&A Chatter

    Benzinga | May. 17, 2015 | 19:41PM EST
  6. Benzinga's Volume Movers

    Benzinga | May. 15, 2015 | 09:49AM EST
  7. H.C. Wainwright's 8 Healthcare Stock Picks

    Benzinga | Jan. 13, 2015 | 07:08AM EST
  8. Conkwest Appoints Robert Rosen And Henry Ji To Its Board Of Directors

    Benzinga | Dec. 29, 2014 | 14:45PM EST
  9. Benzinga's Volume Movers

    Benzinga | Dec. 29, 2014 | 10:35AM EST
  10. US Stock Futures Up Ahead Of Earnings

    Benzinga | Dec. 19, 2014 | 07:48AM EST
  11. Morning Market Movers

    Benzinga | Dec. 15, 2014 | 09:44AM EST
  12. Sorrento Announces Strategic Investment By And Collaboration With Nantworks Founder Dr. Patrick Soon-Shiong For The Advancement Of Cancer Immunotherapies

    Benzinga | Dec. 15, 2014 | 09:25AM EST
  13. Events for the Week of Nov. 17-21, 2014

    Benzinga | Nov. 17, 2014 | 13:13PM EST
  14. UPDATE: MLV & Co. Initiates Coverage On Sorrento Therapeutics On Good Cynviloq Potential

    Benzinga | Jun. 19, 2014 | 06:57AM EST
  15. Stocks Hitting 52-Week Lows

    Benzinga | Dec. 19, 2013 | 10:33AM EST
Trading Center